Down-regulation of OPA1 in patients with primary open angle glaucoma

Molecular Vision

Volumn 17, Issue , 2011, Pages 1074-1079

  Bosley, Thomas M ^a,b   Hellani, Ali ^c   Spaeth, George L ^d   Myers, Jonathan ^d   Katz, L Jay ^d   Moster, Marlene R ^d   Milcarek, Barry ^b   Abu Amero, Khaled K ^a,e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Department of Anesthesiology   (United States)

^c SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN; CELL PROTEIN; COMPLEMENTARY DNA; OPTIC ATROPHY TYPE 1 PROTEIN; RNA; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOR EYE CHAMBER ANGLE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; EYE EXAMINATION; FEMALE; GENE; GENETIC TRANSCRIPTION; GONIOSCOPY; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; LEUKOCYTE; MALE; OPEN ANGLE GLAUCOMA; OPTIC ATROPHY TYPE 1 GENE; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; PATHOGENESIS; PERIMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

AGED; BETA-GLOBULINS; DNA, MITOCHONDRIAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GLAUCOMA, OPEN-ANGLE; GTP PHOSPHOHYDROLASES; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOCHONDRIA; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VISUAL FIELD TESTS;

EID: 79955601349     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-393. [PMID: 8695555]
2. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991; 266:369-374. [PMID: 2056646]
3. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004; 49:491-508. [PMID: 15325194]
4. Spaeth GL. A new classification of glaucoma including focal glaucoma. Surv Ophthalmol 1994; 38:S9-S17. [PMID: 7940153]
5. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol 1987; 105:1066-1071. [PMID: 3632414]
6. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension. An epidemiological study. Br J Ophthalmol 1975; 59:211-215. [PMID: 1138846]
7. Shin DH, Becker B, Kolker AE. Family history in primary openangle glaucoma. Arch Ophthalmol 1977; 95:598-600. [PMID: 849183]
8. Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol 1994; 1:131-138. [PMID: 8790619]
9. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994; 112:69-73. [PMID: 8285897]
10. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-267. [PMID: 16488940]
11. Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006; 47:2533-2541. [PMID: 16723467]
12. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26:211-215. [PMID: 11017080]
13. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26:207-210. [PMID: 11017079]
14. Buono LM, Foroozan R, Sergott RC, Savino PJ. Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. Curr Opin Ophthalmol 2002; 13:362-370. [PMID: 12441838]
15. Aung T, Ocaka L, Ebenezer ND, Morris AG, Krawczak M, Thiselton DL, Alexander C, Votruba M, Brice G, Child AH, Francis PJ, Hitchings RA, Lehmann OJ, Bhattacharya SS. A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene. Hum Genet 2002; 110:52-56. [PMID: 11810296]
16. Aung T, Ocaka L, Ebenezer ND, Morris AG, Brice G, Child AH, Hitchings RA, Lehmann OJ, Bhattacharya SS. Investigating the association between OPA1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum Genet 2002; 110:513-514. [PMID: 12073024]
17. Powell BL, Toomes C, Scott S, Yeung A, Marchbank NJ, Spry PG, Lumb R, Inglehearn CF, Churchill AJ. Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol Vis 2003; 9:460-464. [PMID: 14551537]
18. Woo SJ, Kim DM, Kim JY, Park SS, Ko HS, Yoo T. Investigation of the association between OPA1 polymorphisms and normal-tension glaucoma in Korea. J Glaucoma 2004; 13:492-495. [PMID: 15534475]
19. Yu-Wai-Man P, Stewart JD, Hudson G, Andrews RM, Griffiths PG, Birch MK, Chinnery PF. OPA1 increases the risk of normal but not high tension glaucoma. J Med Genet 2010; 47:102-105. [PMID: 19581274]
20. Spaeth GL. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 2007; 51:156-157. [PMID: 17401633]
21. Eid TM, Spaeth GL, Bitterman A, Steinmann WC. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Ophthalmology 2003; 110:900-907. [PMID: 12750087]
22. Bayer A, Harasymowycz P, Henderer JD, Steinmann WG, Spaeth GL. Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage. Am J Ophthalmol 2002; 133:758-763. [PMID: 12036666]
23. Read R, Spaeth G. The natural history of cup progression and some specific disc field correlations. Trans Am Acad Ophthalmol Otolaryngol 1974; 78:OP255-OP274. [PMID: 4825055]
24. Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, Sullivan EK, Prum B, Shafranov G, Beck A, Spaeth GL, Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology 2004; 111:2109-2116. [PMID: 15522379]
25. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, Penning LC, Toegel S. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 2010; 11:74-81. [PMID: 20858237]
26. Davies V, Votruba M. Focus on molecules: the OPA1 protein. Exp Eye Res 2006; 83:1003-1004. [PMID: 16563384]
27. Lenaers G, Reynier P, Elachouri G, Soukkarieh C, Olichon A, Belenguer P, Baricault L, Ducommun B, Hamel C, Delettre C. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 2009; 41:1866-1874. [PMID: 19389483]
28. Chan DC. Mitochondrial dynamics in disease. N Engl J Med 2007; 356:1707-1709. [PMID: 17460225]
29. Chevrollier A, Guillet V, Loiseau D, Gueguen N, de Crescenzo MA, Verny C, Ferre M, Dollfus H, Odent S, Milea D, Goizet C, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 2008; 63:794-798. [PMID: 18496845]
30. Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008; 131:352-367. [PMID: 18222991]
31. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006; 126:177-189. [PMID: 16839885]
32. Olichon A, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C, Amati-Bonneau P, Bonneau D, Reynier P, Lenaers G, Belenguer P. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 2007; 211:423-430. [PMID: 17167772]
33. Yu-Wai-Man P, Sitarz KS, Samuels DC, Griffiths PG, Reeve AK, Bindoff LA, Horvath R, Chinnery PF. OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wildtype mtDNA molecules. Hum Mol Genet 2010; 19:3043-3052. [PMID: 20484224]
34. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye (Lond) 2004; 18:1144-1160. [PMID: 15534600]
35. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet 2009; 46:145-158. [PMID: 19001017]
36. Fuhrmann N, Alavi MV, Bitoun P, Woernle S, Auburger G, Leo-Kottler B, Yu-Wai-Man P, Chinnery P, Wissinger B. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy. J Med Genet 2009; 46:136-144. [PMID: 19181907]
37. Abu-Amero KK, Jaber M, Hellani A, Bosley TM. Genomewide expression profile of LHON patients with the 11778 mutation. Br J Ophthalmol 2010; 94:256-259. [PMID: 19726426]
38. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003; 278:7743-7746. [PMID: 12509422]
39. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25:490-513. [PMID: 16962364]
40. Stamova B, Xu H, Jickling G, Bushnell C, Tian Y, Ander BP, Zhan X, Liu D, Turner R, Adamczyk P, Khoury JC, Pancioli A, Jauch E, Broderick JP, Sharp FR. Gene expression profiling of blood for the prediction of ischemic stroke. Stroke 2010; 41:2171-2177. [PMID: 20798371]
41. Liao IH, Sharp FR. Tourette syndrome: gene expression as a tool to discover drug targets. Neurotherapeutics 2010; 7:302-306. [PMID: 20643383]
42. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 2005; 62:210-215. [PMID: 15710849]